Neuland Laboratories Limited — Updates, 01-04-2026: Press Release
01-04-2026 | 01:43 pm
01-04-2026 | 01:43 pm
Neuland Labs appoints Saharsh Davuluri as CEO & MD to lead its next phase of CDMO expansion. The company, having tripled contract services revenue in 3 years, plans significant peptide capacity growth and targets more commercial NCE contracts to become a top API-focused CDMO.
No comments yet. Be the first to comment!
